P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 27 July 2017 | 6:18 pm

Systematically exposing vulnerabilities of cancer cells

Novartis team shares results of a massive oncology experiment with the world to accelerate drug discovery. more ...

Published 27 July 2017 | 5:16 pm

Global Health Fellows: 14 Years of Impact

Pictured above are our 2017 Pfizer Global Health Fellows (from left to right): Lene Juncker-Jensen, Cathy Dunwody, Jon Mason, Sonia Braham, Rockwell Griffen and Kate more ...

Published 27 July 2017 | 1:14 pm

Baxter Completes Acquisition of Claris Injectables, Expanding Generic Injectable Medicines Portfolio

Increases Patient Access to Medicines Provides Platform for Accelerated Growth Expected to be Modestly Accretive to Adjusted Earnings for 2017 more ...

Published 27 July 2017 | 8:17 am

AstraZeneca and Merck establish strategic oncology collaboration

Collaboration aims to maximise the potential of PARP and MEK inhibitors in combination with PD-L1/PD-1 medicines, based on growing scientific evidence that these more ...

Published 27 July 2017 | 8:17 am

Tagrisso significantly improves progression-free survival in the Phase III FLAURA trial for lung cancer

Tagrisso met the primary endpoint, demonstrating a statistically-significant and clinically-meaningful progression-free survival benefit in 1st-line EGFRm non-small cell lung more ...

Published 27 July 2017 | 8:17 am

AstraZeneca reports initial results from the ongoing MYSTIC trial in Stage IV lung cancer

Imfinzi plus tremelimumab combination did not meet a primary endpoint of progression-free survival compared to chemotherapy more ...

Published 27 July 2017 | 8:12 am

TESARO AND TAKEDA ENTER INTO EXCLUSIVE LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE NOVEL CANCER THERAPY NIRAPARIB IN JAPAN

Takeda's Rights Include all Potential Indications for Niraparib in Japan and Rights Excluding Prostate Cancer in South Korea, Taiwan, Russia and Australia more ...

Published 27 July 2017 | 7:10 am

BASF: Considerable earnings growth in second quarter, 2017 outlook raised

Earnings per share of euro1.63 (up 37%), adjusted earnings per share of euro1.78 (up 37%) more ...

Published 27 July 2017 | 7:09 am

Media Release

Roche reports strong performance in the first half of 2017 Group sales increase 5% 1 at constant exchange rates and in Swiss francs more ...

Published 27 July 2017 | 3:02 am

Takeda selected by major index and sustainability rating institutions concerning Corporate Social Responsibility (CSR)

- FTSE4Good Global Index (13 th consecutive year) - Ethibel Excellence Investment Register (third time) - Oekom Prime Status (first time) more ...

Pharma Documentation Ring:
25 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Berlin, September 26 – 29, 2017

Next Annual General Meeting, Berlin, September 26 – 29, 2017